These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19047783)

  • 1. [Renal insufficiency after allogeneic stem cell transplantation in children].
    Kato I; Umeda K; Matsubara H; Hiramatsu H; Watanabe K; Adachi S; Nakahata T
    Rinsho Ketsueki; 2008 Nov; 49(11):1530-5. PubMed ID: 19047783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function after hematopoietic stem cell transplantation in children.
    Hazar V; Gungor O; Guven AG; Aydin F; Akbas H; Gungor F; Tezcan G; Akman S; Yesilipek A
    Pediatr Blood Cancer; 2009 Aug; 53(2):197-202. PubMed ID: 19353620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
    Liu H; Ding JH; Liu BC; Zhao G; Chen BA
    Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of hematopoietic stem cell transplantation in children less than three years of age.
    Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
    Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation.
    Cheuk DK; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
    Transpl Int; 2007 Jan; 20(1):73-81. PubMed ID: 17181656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Tc-99 measurement of glomerular filtration rate vs. calculated creatinine clearance to assess renal function pretransplant in pediatric patients undergoing hematopoietic stem cell transplantation.
    Kletzel M; Pirich L; Haut P; Cohn RA
    Pediatr Transplant; 2005 Oct; 9(5):584-8. PubMed ID: 16176414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation.
    Caliskan Y; Besisik SK; Sargin D; Ecder T
    Bone Marrow Transplant; 2006 Jul; 38(2):141-7. PubMed ID: 16770317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
    Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
    Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcome and cataract development after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Olsson M; Winiarski J
    Acta Ophthalmol Scand; 2007 Nov; 85(7):724-33. PubMed ID: 17725615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.